28246472|t|Melatonin, a novel selective ATF-6 inhibitor, induces human hepatoma cell apoptosis through COX-2 downregulation.
28246472|a|AIM: To clarify the mechanisms involved in the critical endoplasmic reticulum (ER) stress initiating unfolded protein response pathway modified by melatonin. METHODS: Hepatoma cells, HepG2, were cultured in vitro. Flow cytometry and TUNEL assay were used to measure HepG2 cell apoptosis. Western blotting and quantitative reverse transcription-polymerase chain reaction methods were used to determine the protein and messenger RNA levels of ER stress and apoptosis related genes' expression, respectively. Tissue microarray construction from patients was verified by immunohistochemical analysis. RESULTS: In the present study, we first identified that melatonin selectively blocked activating transcription factor 6 (ATF-6) and then inhibited cyclooxygenase-2 (COX-2) expression, leading to enhanced liver cancer cell apoptosis under ER stress condition. Dramatically increased CCAAT-enhancer-binding protein homologous protein level, suppressed COX-2 and decreased Bcl-2/Bax ratio by melatonin or ATF-6 siRNA contributed the enhanced HepG2 cell apoptosis under tunicamycin (an ER stress inducer) stimulation. In clinical hepatocellular carcinoma patients, the close relationship between ATF-6 and COX-2 was further confirmed. CONCLUSION: These findings indicate that melatonin as a novel selective ATF-6 inhibitor can sensitize human hepatoma cells to ER stress inducing apoptosis.
28246472	0	9	Melatonin	Chemical	MESH:D008550
28246472	29	34	ATF-6	Gene	22926
28246472	54	59	human	Species	9606
28246472	60	68	hepatoma	Disease	MESH:D006528
28246472	92	97	COX-2	Gene	5743
28246472	261	270	melatonin	Chemical	MESH:D008550
28246472	281	289	Hepatoma	Disease	MESH:D006528
28246472	297	302	HepG2	CellLine	CVCL:0027
28246472	380	385	HepG2	CellLine	CVCL:0027
28246472	656	664	patients	Species	9606
28246472	767	776	melatonin	Chemical	MESH:D008550
28246472	797	830	activating transcription factor 6	Gene	22926
28246472	832	837	ATF-6	Gene	22926
28246472	858	874	cyclooxygenase-2	Gene	5743
28246472	876	881	COX-2	Gene	5743
28246472	915	927	liver cancer	Disease	MESH:D006528
28246472	993	1042	CCAAT-enhancer-binding protein homologous protein	Gene	1649
28246472	1061	1066	COX-2	Gene	5743
28246472	1081	1086	Bcl-2	Gene	596
28246472	1087	1090	Bax	Gene	581
28246472	1100	1109	melatonin	Chemical	MESH:D008550
28246472	1113	1118	ATF-6	Gene	22926
28246472	1150	1155	HepG2	CellLine	CVCL:0027
28246472	1177	1188	tunicamycin	Chemical	MESH:D014415
28246472	1237	1261	hepatocellular carcinoma	Disease	MESH:D006528
28246472	1262	1270	patients	Species	9606
28246472	1303	1308	ATF-6	Gene	22926
28246472	1313	1318	COX-2	Gene	5743
28246472	1383	1392	melatonin	Chemical	MESH:D008550
28246472	1414	1419	ATF-6	Gene	22926
28246472	1444	1449	human	Species	9606
28246472	1450	1458	hepatoma	Disease	MESH:D006528
28246472	Positive_Correlation	22926	596
28246472	Negative_Correlation	MESH:D008550	22926
28246472	Negative_Correlation	MESH:D008550	5743
28246472	Association	MESH:D006528	5743
28246472	Positive_Correlation	MESH:D008550	1649
28246472	Negative_Correlation	MESH:D008550	MESH:D014415
28246472	Association	MESH:D006528	22926
28246472	Negative_Correlation	MESH:D008550	596
28246472	Negative_Correlation	MESH:D008550	581
28246472	Negative_Correlation	MESH:D008550	MESH:D006528

